Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.14 USD | -0.15% | -1.61% | -10.16% |
May. 24 | Inhibrx Shareholders Approve Sale of INBRX-101 Assets to Sanofi | MT |
May. 09 | Inhibrx, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on Inhibrx, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Inhibrx, Inc.
JMP Securities | |
Credit Suisse | |
Evercore ISI | |
SMBC Nikko |
EPS Revisions
- Stock Market
- Equities
- INBX Stock
- Consensus Inhibrx, Inc.